HelixlyAI Genome Report Prepared for Sample Subject
Report ID HX-2026-0042 · synthetic
Methylation & Metabolism · Document 09 of 24

Lipid Metabolism

Variants associated with Sample Subject's lipid handling and cardiometabolic context, centered on the APOE haplotype. All values below are synthetic and for demonstration only.

3 findings 2 Tier 2 1 Tier 3 Reviewed 2026-01-15

Provenance

Data Provenance verified chain
Document
Lipid Metabolism
Source assembly
GRCh37 (hg19)
Source file SHA-256
0000a1b2c3d4e5f6…4b5c6d7e
Supersedes
prior v1 · SHA 1111f0e9…
Evidence sources
ClinVar, PubMed, dbSNP
Access date
2026-01-15

Per-Gene Findings

Filter:

APOE — ε4-defining Allele Present

Apolipoprotein E · lipid transport
ClinVarTier 2
rs429358 19:45,411,941 TC

The TC genotype carries one APOE ε4-defining allele. The ε4 haplotype associates with higher LDL cholesterol than the ε3 reference.

APOE — ε2-defining Allele Absent

Apolipoprotein E · haplotype completion
ClinVarTier 2
rs7412 19:45,412,079 CC

The CC genotype shows the APOE ε2-defining allele is absent. Combined with rs429358, this resolves the APOE haplotype as ε3/ε4 for this sample.

LPL — S447X Variant Absent

Lipoprotein lipase · triglyceride clearance
dbSNPTier 3
rs328 8:19,819,724 CC

The CC genotype shows the LPL S447X gain-of-function variant is absent. This sample carries the reference LPL allele at this position.

Genotype Table

Variants evaluated in this document — synthetic
rsIDchr:posGenotypeGeneSignificance
rs42935819:45,411,941TCAPOETier 2
rs741219:45,412,079CCAPOETier 2
rs3288:19,819,724CCLPLTier 3
Consult your prescribing clinician. This HelixlyAI report is a synthetic demonstration generated from a consumer DNA export. It is not a diagnosis, prescription, or substitute for professional medical advice. Do not start, stop, or change any medication based on this document. Genotype is one of many factors influencing drug response.